Explore our highly reliable trauma, spinal, and veterinary medical devices trusted by orthopedic specialists worldwide.
Primary total knee arthroplasty (TKA) is highly successful, yet mechanical failure, aseptic loosening, periprosthetic joint infection (PJI), instability, and progressive bone osteolysis necessitate revision procedures. Revision Total Knee Arthroplasty (rTKA) presents extreme surgical challenges due to compromised bone stock and weakened ligamentous structures.
Managing bone loss (using the Anderson Orthopaedic Research Institute (AORI) classification system) requires highly adaptable revision knee implants. To address these critical needs, we engineer modular revision systems equipped with metaphyseal sleeves, offset stems, and highly constrained articular inserts to re-establish anatomical stability and functional joint lines.
Providing state-of-the-art clinical solutions backed by precision manufacturing and comprehensive global support.
Synoviq Medical Technology (China) Co., Ltd. is a professional manufacturer of orthopedic implants and surgical instruments, dedicated to delivering innovative, reliable, and high-quality medical solutions for healthcare professionals worldwide. Since its establishment, Synoviq has focused on research, development, precision manufacturing, and international quality standards, providing comprehensive OEM and ODM services for global medical device brands, distributors, and hospitals.
Our product portfolio includes trauma fixation systems, spinal implants, locking plates, intramedullary nails, external fixation systems, orthopedic screws, surgical instruments, and customized orthopedic solutions. Equipped with advanced CNC machining centers, precision inspection equipment, and modern clean production facilities, we ensure every product meets strict international quality requirements.
Driven by continuous innovation, Synoviq invests heavily in R&D and intelligent manufacturing to enhance product performance, surgical efficiency, and patient outcomes. Our experienced engineering team works closely with customers to develop customized products tailored to different clinical applications and market demands.
| Specification Category | Detailed Corporate Metrics |
|---|---|
| Company Name | Synoviq Medical Technology (China) Co., Ltd. |
| Brand & Founding | Synoviq (Established March 18, 2016) |
| Facility Footprint | 18,600 m² state-of-the-art building area |
| Quality Control Staff | 48 Quality Specialists conducting 100% final & incoming material inspections |
| Analytical Testing Infrastructure | CMM Measurement, Mechanical Testing, Surface Roughness Testing, Hardness Testing, Salt Spray Testing, Sterility Validation |
| Business Models Served | Manufacturer & Exporter (Comprehensive OEM & ODM Capabilities) |
| Target Regions | Europe, North America, South America, Middle East, Southeast Asia |
| Customization Capabilities | Logo Etching, Customized Packaging, Anatomical Geometry Adjustments, Material & Coating Treatments |
| R&D Innovation Pace | 186 new medical devices released in the last fiscal year |
Minimizing wear debris and maximizing implant longevity with advanced biomedical alloys and ultra-clean cross-linked polymers.
Utilized for revision tibial trays, femoral components, and modular stems. Excellent biocompatibility and a modulus of elasticity closer to cortical bone, significantly minimizing stress-shielding concerns.
Providing ultra-smooth articulation interfaces to drastically limit wear rates. This high-strength alloy is ideal for the load-bearing surfaces of modular femoral components.
Our articulating inserts employ Ultra-High-Molecular-Weight Polyethylene (UHMWPE) and Highly Cross-Linked Polyethylene (XLPE) enriched with Vitamin E to combat free-radical oxidative degradation.
Located in China's premier high-tech orthopedic manufacturing cluster, Synoviq harnesses an integrated supply chain that links raw titanium smelting, high-precision machining, and sterile packaging. This cluster reduces logistical overheads and minimizes delays.
With an annual export revenue of USD 21.8 million and partnerships with over 1,120 supply chain entities, we maintain rapid turnaround times. Standard OEM requests are fabricated, surface-treated, quality-tested, and sterilized within weeks, providing a distinct market advantage for global medical brands.
How Synoviq secures market access with robust clinical documentation and state-of-the-art testing protocols.
Every single implant undergoes rigorous dimensional validation using coordinate measuring machines (CMM), surface roughness profiling, and radiographic material verification.
Our quality management system is fully aligned with ISO 13485 regulations. We maintain deep clinical documentation files required for CE MDR (2017/745) and FDA 510(k) clearances.
Washing, assembly, and packaging processes occur within certified Class 100,000 / Class 10,000 cleanrooms. This limits bioburden levels prior to final gamma radiation sterilization.
No two hospitals operate under the exact same clinical protocols. To address localized procedural demands, Synoviq offers customizable surgeon toolkits, specialized implant dimensions, and variable offset options tailored to regional patient demographics.
We provide localized technical assistance, regulatory registration dossiers, and surgeon training materials. This helps global distributors clear regulatory registration hurdles faster and build trust within their local hospital networks.
A closer look at our advanced manufacturing lines and quality assurance equipment supporting orthopedic design.
How technological progress is altering the landscapes of orthopedic revision procedures.
Additive manufacturing processes are replacing traditional solid stems. These porous titanium structures allow rapid biological bone ingrowth (osseointegration) directly into the revision knee implant, bypassing the need for bone cement.
Advanced preoperative planning software integrates patients' CT scans to construct customized cutting blocks. In the near future, custom-designed, patient-specific revision knee prostheses will become standard for severe, unique bone defects.
Implants coated with hydroxyapatite (HA) or silver-doped mineral coatings are showing promise in reducing post-operative periprosthetic joint infections (PJI), the leading cause of early-stage revision surgery failures.
Providing clear, clinical, and regulatory explanations for orthopedic distributors, sourcing managers, and surgical partners.
Complementary surgical implants designed to support orthopedic trauma, arthroscopy, and revision operations.
Synoviq Medical